Brain Tumor Treatment: Considering Clinical Trials

Only a tiny percentage of adult cancer patients participate in clinical trials, research that is the single most important component of medical research. Brain tumor patients have a lot of factors to evaluate when considering joining a clinical trial. Here are four perspectives from the Brains for the Cure video library.

Dr. Edward Pan is a neuro-oncologist at UT Southwestern Medical Center in Dallas, TX.
Tammy Marks is a 5-year glioblastoma survivor and current participant in a clinical trial.
Dr. Roy Jensen is director of the University of Kansas Cancer Center
Dr. Nina Paleologos is Director of Neuro-oncology & Director of Neurology, Advocate Medical Group in Chicago, IL

Share this post

Share on facebook
Share on twitter
Share on pinterest
Share on email

Get the Latest from Brains for the Cure

Add your address to our mailing list to get monthly updates about progress in the fight against brain tumors, as well as new community opportunities.

Brains for the Cure is a program of the Head for the Cure Foundation, which is powered by the generous support of donors. Learn more about how you can join the fight.